Functional BRM promoter polymorphisms, pancreatic adenocarcinoma risk, and survival

被引：0

作者：

Segedi, Maja

Anderson, Laura N.

Espin-Garcia, Osvaldo

Borgida, Ayelet

Bianco, Teresa

Cheng, Dangxiao

Chen, Zhuo

Patel, Devalben

Brown, M. Catherine

Hung, Rayjean J.

Cotterchio, Michelle

Gallinger, Steven

Xu, Wei

Reisman, David

Liu, Geoffrey

Cleary, Sean P.

机构：

[1] Univ Toronto, Toronto, ON, Canada

[2] Mt Sinai Hospita Lunenfeld Res Inst, Toronto, ON, Canada

[3] Univ Toronto, Ontario Canc Inst, Lunenfeld Res Inst, Princess Margaret Canc Ctr,Mt Sinai Hosp,Univ Hlt, Toronto, ON M5S 1A1, Canada

[4] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada

[5] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada

[6] Univ Toronto, Ontario Canc Inst, Princess Margaret Canc Ctr, Toronto, ON M5S 1A1, Canada

[7] Univ Florida, Gainesville, FL USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期

关键词：

D O I：

10.1200/jco.2014.32.3_suppl.222

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

222

引用

页数：1

共 50 条

[21] Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma
Wheatley-Price, Paul
Asomaning, Kofi
Reid, Amy
Zhai, Rihong
Su, Li
Zhou, Wei
Zhu, Andrew
Ryan, David P.
Christiani, David C.
Liu, Geoffrey
CANCER, 2008, 112 (05) : 1037 - 1042
[22] Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk
Liu, G.
Gramling, S.
Munoz, D.
Cheng, D.
Azad, A. K.
Mirshams, M.
Chen, Z.
Xu, W.
Roberts, H.
Shepherd, F. A.
Tsao, M. S.
Reisman, D.
ONCOGENE, 2011, 30 (29) : 3295 - 3304
[23] Excellent Survival of Low-Risk Patients With Resected Pancreatic Adenocarcinoma
Hartwig, W.
Hackert, T.
Gluth, A.
Hinz, U.
Bergmann, F.
Buechler, M. W.
Werner, J.
PANCREAS, 2010, 39 (08) : 1322 - 1322
[24] Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk
G Liu
S Gramling
D Munoz
D Cheng
A K Azad
M Mirshams
Z Chen
W Xu
H Roberts
F A Shepherd
M S Tsao
D Reisman
Oncogene, 2011, 30 : 3295 - 3304
[25] Pathologic upstaging in resected pancreatic adenocarcinoma: Risk factors and impact on survival
Olecki, Elizabeth J.
Stahl, Kelly A.
Torres, Madeline B.
Peng, June S.
Shen, Chan
Dixon, Matthew E. B.
Gusani, Niraj J.
JOURNAL OF SURGICAL ONCOLOGY, 2021, 124 (01) : 79 - 87
[26] Effect of BRM Promoter Polymorphisms on Survival Outcomes of Platinum-Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
Cuffe, Sinead
Cheng, Lu
Azad, Abul Kalam
Brhane, Yonathan
Cheng, Dangxiao
Chen, Zhuo
Qiu, Xiaoping
Boyd, Kevin
Xu, Wei
Shepherd, Frances A.
Tsao, Ming-Sound
Reisman, David
Liu, Geoffrey
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 325 - 326
[27] Functional studies of MTTP promoter polymorphisms
Aminoff, Anna
CHEMISTRY AND PHYSICS OF LIPIDS, 2008, 154 : S37 - S37
[28] Functional analysis of human promoter polymorphisms
Hoogendoorn, B
Coleman, SL
Guy, CA
Smith, K
Bowen, T
Buckland, PR
O'Donovan, MC
HUMAN MOLECULAR GENETICS, 2003, 12 (18) : 2249 - 2254
[29] Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia
Sibley, K
Rollinson, S
Allan, JM
Smith, AG
Law, GR
Roddam, PL
Skibola, CF
Smith, MT
Morgan, GJ
CANCER RESEARCH, 2003, 63 (15) : 4327 - 4330
[30] Functional polymorphisms in the TERT promoter are associated with risk of serious ovarian and breast cancer
Jonathan Beesley
Hilda Pickett
Sharon Johnatty
Xiaoqing Chen
Jun Jun Li
David Rider
Michael Stutz
Diether Lambrecht
Jenny Chang-Claude
Thilo Dork
Marc Goodman
Bart Kiemmney
Elisa Bandera
Linda Kelemen
Shan Wang-Gorke
Ian Campbell
Simon Gayther
Susan Ramus
Ellen Goode
Roger Reddel
Georgia Chenevix-Trench
Hereditary Cancer in Clinical Practice, 10 (Suppl 2)

← 1 2 3 4 5 →